INVA Innoviva Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 47
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 99

EPS in 2026 (TTM): $7.2

Last Report Period Date: Mar 31, 2026

As of June 2026, according to Innoviva's latest financial report, the company's current EPS (TTM) is $7.2. In 2025, the company recorded an earnings per share (EPS) of $4.02, which represents an increase compared to its EPS of $0.37 in 2024. Innoviva's earnings per share for the quarterly report ending on Mar 31, 2026 was $2.52.

INVA earnings history

Historical annual and quarterly earnings per share (EPS) data for Innoviva
EPS (TTM)
$7.2
EPS Growth YoY (Quarterly)
440.5%
EPS (Quarterly)
$2.52
EPS Growth (Quarterly)
6.3%

The annual EPS in 2025 was $4.02, an increase of 986.5% from $0.37 in 2024. For the quarter ending Mar 31, 2026, the EPS was $2.52, showing a 440.5% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $7.2. In 2024, the annual EPS was $0.37, showing a decrease of 86.5% from 2023.

INVA earnings chart

INVA EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
440.5%
EPS growth YoY
986.5%
EPS growth 3Y avg
9.4%
EPS growth 5Y avg
12.7%

Over the last 12 months, Innoviva has registered an EPS growth of 440.5% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 9.4% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 12.7%.

INVA Earnings Waterfall

Breakdown of revenue, profit and net income for Innoviva

INVA Earnings vs Peers

What are the earnings of INVA compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
INVA Innoviva Inc 3.08 986.5% 9.4% 12.7%
OPK Opko Health Inc N/A -275% N/A N/A
ORGO Organogenesis Holdings Inc N/A 1,700% 10.1% 0%

All data is based on quarterly TTM periods, unless otherwise specified.